• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    CBD Brands Must Focus On Health Solutions

    A Post-Pandemic Pause in Home Cleaner Sales

    Hair Color Market on Vibrant Streak Inching Out of Covid-19 Pandemic

    Wellness Industry Thrives with Vitamin-Infused Beverages & Beauty-Boosting Supplements

    Skin Care Soars into 2022 with New Products for Facial Care & Body Skin Health
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    Barentz Develops Electronic Personal Care Product Guide

    P&G Temporarily Closes Downtown Cincinnati Office Due to Potential Security Concerns

    Eucerin Expands into US Sun Protection Market with New Sun Line

    Mielle Organics Appoints Entrepreneur Steve Pamon to Advisory Board

    Major US Retailers Form Charter To Mitigate Racially Biased Experiences in Stores
    Blog
    Online Exclusives
    Glossary
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    3. Estée Lauder

    1. Unilever

    8. Amway

    29. Fancl

    40. Perfumania Holdings Inc.
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    Proposed Senate FDA Legislation Includes Cosmetics Reform

    China Beauty Sales Slow; Blueland Enters Personal Care Category; Lady Gaga’s Cosmetics Relaunch

    Jennifer Lopez Inks Deal with HydraFacial

    Luxury Website, Moda Operandi, Enters Beauty Category

    Global Trend Tracker Celebrates the Return of Her 'What's Next' Innovation Intel Treks
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Barentz Develops Electronic Personal Care Product Guide

    Eucerin Expands into US Sun Protection Market with New Sun Line

    Mielle Organics Appoints Entrepreneur Steve Pamon to Advisory Board

    Major US Retailers Form Charter To Mitigate Racially Biased Experiences in Stores

    Indie Beauty Brand Nails Inc. Creates Chocolate-Scented Nail Polish Line Inspired by Magnum Ice Cream
    Lab Equipment
    Mixing
    Packaging
    Testing

    Aerosol Recycling Initiative Launched by HCPA

    Goodnest Delivers New Options for Sustainable Baby Care Needs

    Colgate-Palmolive Releases 2021 Sustainability & Social Impact Report

    Sustainable Personal Care Brand sk*p Enters Ulta Beauty Stores

    LVMH Creates Cosmetic Packages with Carbon-Negative PET
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Jeen International

    Lubrizol Life Science

    LipoTrue Inc.

    KLK OLEO

    BotanicalsPlus
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Glossary
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Podcasts
    • Videos
    • Infographics
    • eBook
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    New FDA Warning Letters

    US-based contract testing lab and an OTC/cosmetics producer in India flagged by agency.

    New FDA Warning Letters
    FDA's cosmetics Twitter page
    Related CONTENT
    • FDA on CBD
    • FDA Puts Hold on Repeal of Lead Acetate in Hair Dyes
    • FDA Sends Warning Letter to Laboratoires Clarins
    • See You in New York at Suppliers' Day
    • FDA Hosting Public Meeting To Prep for ICCR-13
    06.13.19
    The FDA has issued warning letters to a US-based contract testing lab and an OTC/cosmetics producer in India.

    Advanced Botanical Consulting and Testing Inc., Tustin, CA, was sent a letter following an FDA inspection in November 2018 in which the agency found “significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. See 21 CFR, parts 210 and 211” and the company responded on Dec. 4, 2018. 

    According to FDA, during its inspection, an investigator observed specific violations including, but not limited to, the following:
    Failure to establish and document the accuracy, sensitivity, specificity, and reproducibility of its test methods (21 CFR 211.165(e)).  On multiple occasions, FDA said the firm used test methods to perform microbiological testing for drug products salicylic acid and lidocaine, but lacked assurance that the methods were adequate. You lacked suitability testing to determine whether these methods were appropriate for testing each drug product.
     
    In addition, FDA said the firm failed to ensure that laboratory records included complete data derived from all tests necessary to ensure compliance with established specifications and standards (21 CFR 211.194(a)). Specifcally, notebooks and worksheets for the analysis of “Brd Spect SPF 50” lacked documentation of lot numbers and expiration dates of standards. 
     
    In its response, the testing company stated that it updated notebooks and worksheets to “document the Lot Numbers and Expiry Date for the Standards and CRM used in Tests at all times.” 
     
    “Your response is inadequate because it is unclear whether you performed a global review of all your procedures related to notebooks and worksheets to determine if there is any additional missing information,” said FDA in its letter.
     
    This violation is a repeat observation from a 2012 inspection, noted FDA.
     
    FDA stated the the company failed to routinely calibrate, inspect, or check according to a written program designed to assure proper performance of and to maintain adequate written records of calibration checks and inspections of automatic, mechanical, electronic equipment, or other types of equipment, including computers, used in the manufacture, processing, packing, and holding of a drug product (21 CFR 211.68(a)). FDA said many pieces of equipment that you used for drug product testing were out-of-calibration or not validated. 
     
    FDA said it considers contractors as extensions of the manufacturer’s own facility. 
     
    “Your failure to comply with CGMP may affect the quality, safety, and efficacy of the drugs you test for your clients. It is essential that you understand your responsibility to operate in full compliance with CGMP, and that you inform all your customers of any out-of-specification results or significant problems encountered during the testing of these drugs,” wrote FDA.
     
    A second letter was sent to Glint Cosmetics Pvt. Ltd., a company based in India, following FDA’s inspection of the company’s drug manufacturing facility in Maharashtra in December 2018. FDA said found significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals, rendering its drug products as adulterated.

    According to FDA, Glint Cosmetics is manufacturing Wish Vaporizing Chest Rub (4 oz) and Wish Blue Therapeutic Ice Gel (8 oz) that are unapproved new drugs in violation of section 505(a) of the FD&C Act, 21 U.S.C. 355(a). FDA said that introduction or delivery for introduction of such products into interstate commerce is prohibited.

    FDA also said that Glint-manufactured products AmeriDerm Ointment with Vitamins A&D (15 oz), MedPRIDE Zinc Oxide Ointment (1 oz), GeriGentle Bacitracin Ointment USP (1 oz), GeriGentle Zinc Oxide Ointment (1 oz and 2 oz), GeriGentle Vitamin A&D Ointment (4 oz, 4 oz (12 tubes), and 5 g), geri gard (4 oz), MedPRIDE Vitamins A&D Ointment (4 oz and 1 oz), MedPRIDE En-Shield (3.5 oz), MedPRIDE White Petrolatum (720 g), AmeriDerm PeriShield (3.5 oz), and Wish products (original, cocoa butter, baby, aloe, and lavender (6 oz and 12 oz) are are misbranded under section 502 of the FD&C Act, 21 U.S.C. 352. Introduction or delivery for introduction of such products into interstate commerce is prohibited under section 301(a) of the FD&C Act, 21 U.S.C. 331(a), wrote FDA.

    FDA said it reviewed correspondence from Glint in January 11, 2019, that the company had  “decided to suspend exports to the USA until all corrections have been made.” 
    FDA said, however, that Glint’s drug products were shipped to the United States after this response via your distributor.

    The agency placed Glint on Import Alert 66-40 on April 17, 2019. 

    During FDA’s inspection, the investigator observed specific violations including, but not limited to CGMP Violations 

    FDA said  Glint’s quality control unit failed to exercise its responsibility to ensure drug products manufactured are in compliance with CGMP, and meet established specifications for identity, strength, quality, and purity (21 CFR 211.22).

    During the inspection, an FDA investigator observed that Glint’s quality unit did not provide adequate oversight for the manufacture of over-the-counter (OTC) drug products, and the also firm failed to clean, maintain, and, as appropriate for the nature of the drug, sanitize and/or sterilize equipment and utensils at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements (21 CFR 211.67(a)).

    FDA said that Glint uses non-dedicated equipment to manufacture multiple topical OTC drug products without a validated cleaning process for drug product changeover to prevent cross-contamination between products. 
     
    FDA said its investigator also observed that employees pre-filled and signed logbooks for cleaning and falsified the recorded duration of equipment cleaning. For example, the cleaning of two “scoops” was documented at the exact same time, and for a duration of each day from September to December 2018, despite the facility being closed on some of those days. 
     
    FDA also pointed out label claims made on Wish BLUE THERAPEUTIC ICE GEL (8 oz), which is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B), because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act, 21 U.S.C. 321(g)(1)(C), because it is intended to affect the structure or any function of the body. Specifically, this product is intended as an external analgesic. In addition, FDA said it was  not aware of any adequate and well controlled clinical trials in the published literature that support a determination that Wish BLUE THERAPEUTIC ICE GEL (8 oz) is generally recognized as safe and effective for its labeled indications. Additionally, we are not aware of a similar OTC product as formulated and labeled that was available in the United States market on or before the inception of the OTC Drug Review.

    FDA also took issue with misbranded drugs due to product labels that did not meet requirements:  AmeriDerm Ointment with Vitamins A&D (15 oz), MedPride Zinc Oxide Ointment (1 oz), GeriGentle Bacitracin Ointment USP (1 oz), GeriGentle Zinc Oxide Ointment (1 oz and 2 oz), GeriGentle Vitamin A&D Ointment (4 oz, 4 oz (12 tubes), and 5 g), geri gard (4 oz), MedPride Vitamins A&D Ointment (4oz, 5 g, and 1 oz), MedPride En-Shield (3.5 oz), MedPride White Petrolatum (720 g), AmeriDerm PeriShield (3.5 oz), and Wish products (original, cocoa butter, baby, aloe, and lavender (6 oz and 12 oz)).
    Related Searches
    • topical
    • cleaning
    • baby
    • gel
    Related Knowledge Center
    • Sun Care
    • Skin Care
    • OTC/Medicated
    Suggested For You
    FDA on CBD FDA on CBD
    FDA Puts Hold on Repeal of Lead Acetate in Hair Dyes FDA Puts Hold on Repeal of Lead Acetate in Hair Dyes
    FDA Sends Warning Letter to Laboratoires Clarins FDA Sends Warning Letter to Laboratoires Clarins
    See You in New York at Suppliers See You in New York at Suppliers' Day
    FDA Hosting Public Meeting To Prep for ICCR-13 FDA Hosting Public Meeting To Prep for ICCR-13
    FDA Warns Nutra Pharma FDA Warns Nutra Pharma
    Beauty As a Change Agent Beauty As a Change Agent
    FDA Puts Hold on Repeal of Lead Acetate in Hair Dyes FDA Puts Hold on Repeal of Lead Acetate in Hair Dyes
    Asbestos? In Cosmetics? Asbestos? In Cosmetics?
    Read FDA Read FDA's Statement on Cosmetics Safety
    FDA Commissioner To Resign, Reports Say FDA Commissioner To Resign, Reports Say
    Beauty Innovation and Empowered Women Beauty Innovation and Empowered Women
    FDA Issues Letter to Soleo of Korea FDA Issues Letter to Soleo of Korea
    Telling Your Story On Social Media Telling Your Story On Social Media
    Help Us Pick Our Next Cover! Help Us Pick Our Next Cover!

    Related Content

    • Actives | Functional Ingredients | Skin Care | Testing
      FDA on CBD

      FDA on CBD

      More questions than answers during hearing.
      06.03.19

    • Functional Ingredients | Hair Care

      FDA Puts Hold on Repeal of Lead Acetate in Hair Dyes

      ...
      05.31.19

    • Skin Care

      FDA Sends Warning Letter to Laboratoires Clarins

      Violations recorded at company's manufacturing facility in Pontoise, France.
      05.15.19


    • Color Cosmetics | Hair Care | Skin Care
      See You in New York at Suppliers

      See You in New York at Suppliers' Day

      But if you can’t make it there, don’t despair…..
      05.07.19

    • FDA Hosting Public Meeting To Prep for ICCR-13

      Deadline to register or make oral presentations at June 5 meeting is this month.
      05.02.19

      Breaking News
      • Barentz Develops Electronic Personal Care Product Guide
      • P&G Temporarily Closes Downtown Cincinnati Office Due to Potential Security Concerns
      • Eucerin Expands into US Sun Protection Market with New Sun Line
      • Mielle Organics Appoints Entrepreneur Steve Pamon to Advisory Board
      • Major US Retailers Form Charter To Mitigate Racially Biased Experiences in Stores
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • CBD Brands Must Focus On Health Solutions
      • Hair Color Market Remains Vibrant Post-Pandemic
      • New Skin Care Products for Facial Care & Body Skin Health
      • Vitamin-Infused Beverages & Beauty Supplements Lift Wellness
      • Laboratory Skin Care’s Hydroxysomes Dermal Delivery Platform
      • Formulating Skin Care Products with Pear Enzyme Technology
      • A Post-Pandemic Pause in Home Cleaner Sales

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Jordan Process Receives Nutrasource ICAP Certification for CBD
      FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements
      Nootropics and Adaptogens Respond to Demand for Mind and Mood Support
      Coatings World

      Latest Breaking News From Coatings World

      AGM Secures Exclusive Distribution Agreement with Indian Partner Imkemex
      Microban Announced as Lead Sponsor of BCF Annual Conference and Dinner 2022
      DIC’s Indian Subsidiary Begins Construction of Coating Resins Production Facility
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Innosuisse Awards $12.1 Million to Project for Futuristic Surgical Training
      XACT ACE OK'ed for Robotic Ablation Probe Insertion, Steering
      Nonin Medical Appoints Five New Board Members
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Grand Opening of Kodiak Sciences’ Bioconjugation Facility
      Vertex Expands Cell and Gene Therapy Footprint
      AffyXell Expands Manufacturing Partnership with GenScript ProBio
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Nu Skin Joins EcoBeautyScore Consortium
      Nails Inc Partners with Magnum, Expands Chocolate-Scented Nail Polish Line
      Aveda is Leaping Bunny Approved by Cruelty Free International
      Happi

      Latest Breaking News From Happi

      Barentz Develops Electronic Personal Care Product Guide
      P&G Temporarily Closes Downtown Cincinnati Office Due to Potential Security Concerns
      Eucerin Expands into US Sun Protection Market with New Sun Line
      Ink World

      Latest Breaking News From Ink World

      Epson Introduces First Direct-to-Fabric Printer for North America
      ProAmpac Facilities Secure Safety Awards 2022
      Ball Corporation Enters Agreement for New Wind Energy
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      In-Mold Decorating Association announces 2022 IMDA Awards Competition
      Essentra Packaging invests in Landa Nanographic press
      Nazdar to manufacture VFP electronic ink for US Market
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      'Right' Hygiene Conference to be Held in June
      Freudenberg to Present Battery Pack and Liquid Absorbers at Battery Show
      H&V Appoints Vice President and General Counsel
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Exactech Earns Breakthrough Status for JointMedica's Polymotion Hip Resurfacing
      Orthotic Brace Suppliers Convicted in $6.5M Fraud Scheme
      GE Additive and Orchid Partner to Advance Scalable Metal 3D Printing
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Emerson Earns Third Consecutive 2022 ENERGY STAR Partner of the Year Award
      First Solar to Sell Japan Project Development, O&M Platforms to PAG Real Assets
      Jabil Strengthens Additive Manufacturing Offerings

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login